Alivus Life Sciences Limited has informed the Exchange about Schedule of meet
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences (formerly Glenmark Life Sciences) has informed the exchanges about an earnings call scheduled for Friday, May 16, 2025, from 8:30 am to 9:30 am IST. The call will cover the company's Q4 FY2024-25 and full-year FY2024-25 financial performance. The company has shared domestic and international dial-in numbers along with an online pre-registration link for participants. Contact persons for queries are Diwakar Pingle and Runjhun Jain from EY. The letter was signed by Rudalf Corriea, Company Secretary & Compliance Officer.
This is a routine procedural disclosure with no immediate impact on the stock. Investors should watch the May 16 earnings call for actual Q4 and full-year FY25 results, which could move the stock depending on the numbers and management commentary.